Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-130030

10% owner acquired 680,825 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Merck KGaA · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-10-26 Conversion : show line 1 in the form +416,060 416,060 I
2021-10-26 Conversion : show line 2 in the form +264,765 680,825 I

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-10-26 Conversion : show line 3 in the form Series B Preferred Stock −3,952,568 0 I
2021-10-26 Conversion : show line 4 in the form Series C Preferred Srock −2,515,271 0 I
Loading xslF345X03/tm2130646-26_4seq1.xml…